Category: St. Jude MedicalSyndicate content

Covidien shareholder files class action lawsuit blocking company's merger with Medtronic | The week in medtech M&A

July 16, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Shareholder files class action lawsuit to block Covidien-Medtronic merger; St. Jude drops $200M on NeuroTherm for spinal pain device; Allergan renews fight against hostile Valeant takeover; Abbott to deal pharma line to Mylan for $5.3B

Shareholder files class action lawsuit to block Covidien-Medtronic merger

July 11, 2014 by Brad Perriello

Analyst: St. Jude Medical's Q2 results could signal ICD rebound

July 16, 2014 by Brad Perriello

St. Jude Medical's 2nd-quarter results, including a 2% gain for its implantable cardiac defibrillator business, could signal a rebound for the ICD sector overall, according to Leerink Partners.

Analyst: St. Jude Medical's Q2 results could signal ICD rebound

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude drops $200M on NeuroTherm for spinal pain device

July 14, 2014 by Arezu Sarvestani

St. Jude Medical enters the spinal pain treatment arena with the $200 million cash acquisition of NeuroTherm and its radiofrequency ablation technology.

St. Jude drops $200M on NeuroTherm for spinal pain device

Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA reveals 4-year plan | Regulatory news for the week of July 7, 2014

July 8, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA aims to stay the course in new 4-year plan; Medical device recalls for June 2014; Medtronic issues Class I recall of Duet neuro drainage and monitoring systems; FDA warns Staar Surgical for missing documentation; FDA clears St. Jude Medical after 2013 warning letter

FDA aims to stay the course in new 4-year plan

July 2, 2014 by Arezu Sarvestani

FDA reveals 4-year plan

Podcast: Medical device execs react to Medtronic-Covidien deal, M&A activity at DeviceTalks Minnesota

July 3, 2014 by Brian Johnson

MassDevice.com speaks to 3M's Deb Rectenwald, St. Jude Medical's Philip Ebeling and Nadim Yared, CEO of CVRx, about the environment for M&A in medtech following the $43 billion Medtronic/Covidien deal.

MassDevice.com DeviceTalks

Most claims preempted in trio of Riata suits against St. Jude Medical

July 3, 2014 by Brad Perriello

A federal judge rules that most of the product liability claims against St. Jude Medical are preempted in a trio of lawsuits filed over its recalled Riata defibrillator leads.

Most Riata claims preempted in trio of suits against St. Jude Medical

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp